PerCP/Cyanine5.5 anti-human IL-9 Antibody
- 产品名称：
- PerCP/Cyanine5.5 anti-human IL-9 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 507609
- 产品应用：
- 507609
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1632 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Baculovirus-expressed, recombinant human IL-9
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PerCP/Cyanine5.5 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
ICFC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.
- Excitation Laser
- Blue Laser (488 nm)
- Application Notes
ELISA Capture2: The purified MH9A4 antibody is useful as the capture antibody in a human IL-9 sandwich ELISA assay, when used in conjunction with the biotinylated MH9D1 antibody as the detecting antibody.
For human IL-9 neutralization assay, the LEAF? purified MH9D1 antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for neutralization of human IL-9 bioactivity.
- Additional Product Notes
- BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Jenmalm M, et al. 2001. Clin. Exptl. Aller. 31:1528.
- Faulkner H, et al. 2002. J. Infec. Diseas. 185:665.
- Chen J, et al. 2008. Blood 111:5163. PubMed
- Chang HC, et al. 2010. Nat. Immunol. 11:527. (ELISA) PubMed
- Lozano E, et al. 2012. J Immunol. 188:3869. PubMed.
- Product Citations
-
- Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
- Chang T, et al. 2020. Aging (Albany NY). 12:21147. PubMed
- RRID
- AB_2564550 (BioLegend Cat. No. 507609) AB_2564551 (BioLegend Cat. No. 507610)
- Structure
- Cytokine; 32-39 kD (Mammalian)
- Bioactivity
- Potentiates production of IgG, IgM, and IgE by IL-4-induced B lymphocytes; regulates granzyme family proteases; enhances proliferation of bone marrow mast cells with IL-3; production of IL-6 by mast cells
- Cell Sources
- IL-2 activated TH2 lymphocytes, Hodgkin's lymphoma
- Cell Targets
- T lymphocytes, erythroid precursors
- Receptors
- IL-9R
- Biology Area
- Immunology
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Quesniaux V. 1992. Research Immunology 143:385.
3. Renauld J, et al. 1993. Adv. Immunol. 54:79.
4. Yang Y. 1992. Leuk. Lymphoma 8:441.
- Regulation
- Upregulated by IL-1 after TCR activation, TNF-α; downregulated by antibodies to IL-2
- Gene ID
- 3578 View all products for this Gene ID
- UniProt
- View information about IL-9 on UniProt.org
